Study finds genetic counseling gaps among breast cancer survivors

FHS
July 17, 2024
7:19 pm

As cancer treatment and survivorship care relies more on understanding the genetic make-up of an individual’s tumor, a new study from the University of Michigan Health Rogel Cancer Center finds that many breast cancer survivors who meet criteria for genetic counseling and testing are not receiving it.

MindBio Therapeutics Corp. Announces Sustained Antidepressant Response 3-Months Post Treatment in Microdosing Depression Clinical Trials | Psychedelic Invest

MindBio Therapeutics Corp. reported durability data from Phase 2A clinical trials in depressed patients testing MB22001, MindBio’s proprietary self-administered take home microdose of Lysergic Acid

August 20, 2024

Pα+ Library: Psychedelic REMS – Psychedelic Alpha

Written by Psychedelic Alpha Medical Advisor Michael Haichin, PharmD, and Josh Hardman as part of the Pα+ Library. As we look ahead to potential approvals

November 15, 2023

GE HealthCare Receives FDA Clearance for Alzheimer’s Imaging Tool

What You Should Know: – GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA)

October 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.